[ANTIBACTERIAL TREATMENT IN PATIENTS AFFLICTED WITH PULMONARY TUBERCULOSIS CAUSED BY MYCOBACTERIA RESISTANT TO THE MAJOR CHEMO-ANTIBIOTICS].
D010131:Aminosalicylic Acid; D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003096:Collapse Therapy; D003523:Cycloserine; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D005000:Ethionamide; D007538:Isoniazid; D007612:Kanamycin; D011013:Pneumonectomy; D011718:Pyrazinamide; D013307:Streptomycin; D014397:Tuberculosis, Pulmonary
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D011718:Pyrazinamide; D007612:Kanamycin; D010131:Aminosalicylic Acid; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D013307:Streptomycin
AMINOSALICYLIC ACID; COLLAPSE THERAPY; CYCLOSERINE; DRUG RESISTANCE, MICROBIAL; ETHIONIAMIDE; ISONIAZID; KANAMYCIN; PNEUMONECTOMY; PYRAZINAMIDE; STREPTOMYCIN; TUBERCULOSIS, PULMONARY
IL TRATTAMENTO ANTIBATTERICO NEI PAZIENTI AFFETTI DA TUBERCOLOSI POLMONARE SOSTENUTA DA MICOBATTERI RESISTENTI AI CHEMIO-ANTIBIOTICI MAGGIORI.